Literature DB >> 8941227

Neurologic manifestations of HIV infection.

D M Simpson1, J R Berger.   

Abstract

A wide spectrum of central and peripheral nervous system abnormalities may be associated with HIV infection. These disorders may be caused by HIV infection, result as secondary complications related to immunosuppression, or be a neurotoxic effect of therapeutic agents. The range of neurologic disorders includes dementia, focal cerebral mass lesions, myelopathy, peripheral neuropathies, and myopathy. Early diagnosis and therapy is critical, and may result in substantial improvement in patients' quality and quantity of life. This article reviews the approach to differential diagnosis of these neurologic disorders and presents theories of pathogenesis and current approaches to treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941227     DOI: 10.1016/s0025-7125(05)70494-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  5 in total

1.  Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

Authors:  C G Filippi; A M Ulug; E Ryan; S J Ferrando; W van Gorp
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Gene Expression Profiling of Tuberculous Meningitis Co-infected with HIV.

Authors:  Ghantasala S Sameer Kumar; Abhilash K Venugopal; Manoj Kumar Kashyap; Rajesh Raju; Arivusudar Marimuthu; Shyam Mohan Palapetta; Yashwanth Subbanayya; Renu Goel; Ankit Chawla; Jyoti Bajpai Dikshit; Pramila Tata; H C Harsha; Jagadeesha Maharudraiah; Y L Ramachandra; Parthasarathy Satishchandra; T S Keshava Prasad; Akhilesh Pandey; Anita Mahadevan; S K Shankar
Journal:  J Proteomics Bioinform       Date:  2012-09-09

3.  Retinoid-induced mu opioid receptor expression by phytohemagglutinin-stimulated U937 cells.

Authors:  Walter Royal; Michelle V Leander; Reid Bissonnette
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

4.  HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study.

Authors:  Jade C Mogambery; Halima Dawood; Douglas Wilson; Anand Moodley
Journal:  South Afr J HIV Med       Date:  2017-09-26       Impact factor: 2.744

5.  Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C Study.

Authors:  John S Schieffelin; Paige L Williams; Divna Djokic; Jeffrey P Anderson; Sharon Nachman; James M Oleske; George R Seage; Russell B Van Dyke
Journal:  J Pediatric Infect Dis Soc       Date:  2012-10-26       Impact factor: 3.164

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.